176 related articles for article (PubMed ID: 30959530)
1. Elevated C-reactive Protein Levels Independently Predict the Development of Prediabetes Markers in Subjects with Normal Glucose Regulation.
Kato K; Otsuka T; Saiki Y; Kobayashi N; Nakamura T; Kon Y; Kawada T
Exp Clin Endocrinol Diabetes; 2021 Mar; 129(4):289-295. PubMed ID: 30959530
[TBL] [Abstract][Full Text] [Related]
2. Association Between Elevated C-Reactive Protein Levels and Prediabetes in Adults, Particularly Impaired Glucose Tolerance.
Kato K; Otsuka T; Saiki Y; Kobayashi N; Nakamura T; Kon Y; Kawada T
Can J Diabetes; 2019 Feb; 43(1):40-45.e2. PubMed ID: 30026044
[TBL] [Abstract][Full Text] [Related]
3. Toward targeted prevention: risk factors for prediabetes defined by impaired fasting glucose, impaired glucose tolerance and increased HbA1c in the population-based KORA study from Germany.
Greiner GG; Emmert-Fees KMF; Becker J; Rathmann W; Thorand B; Peters A; Quante AS; Schwettmann L; Laxy M
Acta Diabetol; 2020 Dec; 57(12):1481-1491. PubMed ID: 32748175
[TBL] [Abstract][Full Text] [Related]
4. Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes.
Kim YA; Ku EJ; Khang AR; Hong ES; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Lim S
Diabetes Res Clin Pract; 2014 Nov; 106(2):351-9. PubMed ID: 25245975
[TBL] [Abstract][Full Text] [Related]
5. Postload hyperglycemia is associated with increased subclinical inflammation in patients with prediabetes.
Colak A; Akinci B; Diniz G; Turkon H; Ergonen F; Yalcin H; Coker I
Scand J Clin Lab Invest; 2013 Aug; 73(5):422-7. PubMed ID: 23767858
[TBL] [Abstract][Full Text] [Related]
6. Elevated level of C-reactive protein is associated with risk of prediabetes in Indians.
Jaiswal A; Tabassum R; Podder A; Ghosh S; Tandon N; Bharadwaj D
Atherosclerosis; 2012 Jun; 222(2):495-501. PubMed ID: 22464286
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.
Andes LJ; Cheng YJ; Rolka DB; Gregg EW; Imperatore G
JAMA Pediatr; 2020 Feb; 174(2):e194498. PubMed ID: 31790544
[TBL] [Abstract][Full Text] [Related]
8. Physical Activity and Improvement of Glycemia in Prediabetes by Different Diagnostic Criteria.
Færch K; Witte DR; Brunner EJ; Kivimäki M; Tabák A; Jørgensen ME; Ekelund U; Vistisen D
J Clin Endocrinol Metab; 2017 Oct; 102(10):3712-3721. PubMed ID: 28973497
[TBL] [Abstract][Full Text] [Related]
9. Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).
Chakarova N; Tankova T; Atanassova I; Dakovska L
Diabetes Res Clin Pract; 2009 Oct; 86(1):56-60. PubMed ID: 19674805
[TBL] [Abstract][Full Text] [Related]
10. Prognostic association of HbA1c and fasting plasma glucose with reduced kidney function in subjects with and without diabetes mellitus. Results from a population-based cohort study from Germany.
Schöttker B; Brenner H; Koenig W; Müller H; Rothenbacher D
Prev Med; 2013 Nov; 57(5):596-600. PubMed ID: 23948106
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia.
Yip WCY; Sequeira IR; Plank LD; Poppitt SD
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29165385
[TBL] [Abstract][Full Text] [Related]
12. The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension.
Geva M; Shlomai G; Berkovich A; Maor E; Leibowitz A; Tenenbaum A; Grossman E
Cardiovasc Diabetol; 2019 Apr; 18(1):53. PubMed ID: 31029146
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk factors, carotid artery intima media thickness, and HSCRP levels in patients with impaired glucose metabolism.
Karbek B; Cakal E; Cakir E; Bozkurt N; Unsal I; Sahin M; Delibaşi T
Minerva Endocrinol; 2013 Sep; 38(3):297-304. PubMed ID: 24126550
[TBL] [Abstract][Full Text] [Related]
14. Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population.
Li CH; Chou YT; Shen WC; Lu FH; Yang YC; Wu JS; Chang CJ
J Diabetes Investig; 2020 Sep; 11(5):1336-1343. PubMed ID: 32270583
[TBL] [Abstract][Full Text] [Related]
15. Association between prediabetes (defined by HbA1
Kim GS; Oh HH; Kim SH; Kim BO; Byun YS
BMC Nephrol; 2019 Apr; 20(1):130. PubMed ID: 30992067
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
[TBL] [Abstract][Full Text] [Related]
17. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
[TBL] [Abstract][Full Text] [Related]
18. Associations between GDF15 levels and pre-diabetes in non-obese subjects.
Hung HC; Wu HT; Lin CH; Chou HW; Ou HY; Chang CJ
J Investig Med; 2022 Jan; 70(1):79-84. PubMed ID: 34376526
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and beta-cell dysfunction in people with prediabetes according to criteria based on glycemia and glycosylated hemoglobin.
Tura A; Göbl C; Moro E; Pacini G
Endocr J; 2017 Jan; 64(1):117-122. PubMed ID: 27628439
[TBL] [Abstract][Full Text] [Related]
20. Does the Effect of a 3-Year Lifestyle Intervention on Body Weight and Cardiometabolic Health Differ by Prediabetes Metabolic Phenotype? A Post Hoc Analysis of the PREVIEW Study.
Zhu R; Jalo E; Silvestre MP; Poppitt SD; Handjieva-Darlenska T; Handjiev S; Huttunen-Lenz M; Mackintosh K; Stratton G; Navas-Carretero S; Pietiläinen KH; Simpson E; Macdonald IA; Muirhead R; Brand-Miller J; Fogelholm M; Færch K; Martinez JA; Westerterp-Plantenga MS; Adam TC; Raben A
Diabetes Care; 2022 Nov; 45(11):2698-2708. PubMed ID: 35696263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
